| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vtv Therapeutics Inc. (VTVT) has 2 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. VTVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.40M | $84.12M | - | |
| Dir | 877.2K | $30.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2018 | Perelman Ronald O | 10% Owner | Buy | 570,776 | $4.38 | $2,499,998.88 | +17.9% | |
| May 24, 2018 | Perelman Ronald O | 10% Owner | Buy | 570,776 | $4.38 | $2,499,998.88 | +21.8% | |
| Dec 26, 2017 | Perelman Ronald O | 10% Owner | Buy | 50,000 | $4.03 | $201,720.00 | +1.9% | |
| Dec 7, 2017 | Savas Paul G | Director | Buy | 15,000 | $4.56 | $68,357.00 | +9.8% | |
| Aug 22, 2017 | Perelman Ronald O | 10% Owner | Buy | 20,000 | $4.57 | $91,324.00 | +0.8% | |
| Aug 16, 2017 | Perelman Ronald O | 10% Owner | Buy | 10,000 | $4.97 | $49,678.00 | +0.4% | |
| Aug 15, 2017 | Perelman Ronald O | 10% Owner | Buy | 50,000 | $4.72 | $235,964.50 | +1.0% | |
| Aug 11, 2017 | Perelman Ronald O | 10% Owner | Buy | 85,000 | $4.13 | $350,864.50 | +1.7% | |
| May 15, 2017 | Savas Paul G | Director | Buy | 3,000 | $5.18 | $15,542.84 | +2.2% | |
| Mar 31, 2017 | Savas Paul G | Director | Buy | 10,000 | $6.50 | $64,964.58 | +8.0% |